Tests from Roche, Siemens and Becton Dickinson Get FDA Approval in MarchApril 20th, 2018
Eppendorf Starts Off 2018 Introducing Two New Benchtop CentrifugesApril 18th, 2018
MEDICA 2017 - World Forum for Medicine
Düsseldorf, GermanyBooth No.: 3/D35-2
AACC Annual Scientific Meeting and Clinical Lab Expo
ChicagoBooth No.: 3849
Medlab - The World’s Largest Expo
DubaiBooth No.: Z5 G 42
69th AACC Annual Meeting and Clinical Lab Expo - July 30 - August 3, 2017
SAN DIEGO, CA, USA
Thanks to Block Scientific, I was able to procure the re-certified Bayer DCA 2000+ without hassles and get the lab back in operation. The
device works perfectly and I look forward to doing more business with Block Scientific.
--- Mathew Anderson, New Jersey
HDL-Cholesterol test kit (liquid stable), R1: 4 x 70 ml R2: 2 x 50 ml
The Diazyme HDL-Cholesterol assay is a direct dual liquid stable reagent system which can be used reliably with fasting and non-fasting specimens. Convenient instrument specific packaging options including Roche Hitachi 917 series, Olympus AU (400/600/640/680), Beckman Synchron CX, LX and DXC. The assay utilizes Diazyme’s proprietary PVS\PEGME coupled technology which provides outstanding performance. The assay features a linear range of 1.06 to 184.8 mg/dL, intra and inter %CV values < 5 % and less than 10% interference from triglycerides to 1000 mg/dL, ascorbic acid to10 mmol/L, bilirubin to 40 mg/dL, bilirubin conjugate to 30 mg/dL, hemoglobin to 1000 mg/dL. Stable for 15 months from date of certification when stored @ 2° - 8° C.
The assay is based on a modified polyvinyl sulfonic acid (PVS) and polyethylene-glycol-methyl ether (PEGME) coupled classic precipitation method with the improvements in using optimized quantities of PVS/PEGME and selected detergents. LDL, VLDL and chylomicron (CM) react with PVS and PEGME and the reaction results in inaccessibility of LDL, VLDL and CM by cholesterol oxidase (CHOD) and cholesterol esterase (CHER). The enzymes selectivity react with HDL to produce H2O2 which is detected through a Trinder reaction.
The Diazyme HDL-Cholesterol reagent is intended for the in vitro quantitative determination of High Density Lipoprotein Cholesterol in human serum or plasma. The reagent can assist in the diagnosis and treatment of patients at risk for developing coronary heart disease.